Used as a key intermediate in the synthesis of biologically active compounds, particularly in pharmaceuticals targeting central nervous system disorders. Its structure enables incorporation into molecules requiring enhanced binding affinity and metabolic stability. Commonly utilized in the development of kinase inhibitors and receptor modulators due to the fluoromethyl azetidine moiety, which improves pharmacokinetic properties. Also employed in medicinal chemistry for structure-activity relationship (SAR) studies, where the hydroxyl group allows further functionalization or conjugation.